176 related articles for article (PubMed ID: 10899326)
1. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence.
Suárez T; Nir S; Goñi FM; Saéz-Cirión A; Nieva JL
FEBS Lett; 2000 Jul; 477(1-2):145-9. PubMed ID: 10899326
[TBL] [Abstract][Full Text] [Related]
2. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
Pereira FB; Goñi FM; Muga A; Nieva JL
Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
[TBL] [Abstract][Full Text] [Related]
3. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.
Suárez T; Gallaher WR; Agirre A; Goñi FM; Nieva JL
J Virol; 2000 Sep; 74(17):8038-47. PubMed ID: 10933713
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage.
Nieva JL; Nir S; Muga A; Goñi FM; Wilschut J
Biochemistry; 1994 Mar; 33(11):3201-9. PubMed ID: 8136355
[TBL] [Abstract][Full Text] [Related]
5. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
[TBL] [Abstract][Full Text] [Related]
6. Role of the ectodomain of the gp41 transmembrane envelope protein of human immunodeficiency virus type 1 in late steps of the membrane fusion process.
Bär S; Alizon M
J Virol; 2004 Jan; 78(2):811-20. PubMed ID: 14694113
[TBL] [Abstract][Full Text] [Related]
7. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.
Pritsker M; Jones P; Blumenthal R; Shai Y
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7287-92. PubMed ID: 9636141
[TBL] [Abstract][Full Text] [Related]
8. The hydrophobic internal region of bovine prion protein shares structural and functional properties with HIV type 1 fusion peptide.
Sáez-Cirión A; Nieva JL; Gallaher WR
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):969-78. PubMed ID: 14678604
[TBL] [Abstract][Full Text] [Related]
9. Structure and interaction with membrane model systems of a peptide derived from the major epitope region of HIV protein gp41: implications on viral fusion mechanism.
Contreras LM; Aranda FJ; Gavilanes F; González-Ros JM; Villalaín J
Biochemistry; 2001 Mar; 40(10):3196-207. PubMed ID: 11258936
[TBL] [Abstract][Full Text] [Related]
10. Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution.
Pereira FB; Goñi FM; Nieva JL
FEBS Lett; 1995 Apr; 362(2):243-6. PubMed ID: 7720880
[TBL] [Abstract][Full Text] [Related]
11. Conformational transitions of membrane-bound HIV-1 fusion peptide.
Sáez-Cirión A; Nieva JL
Biochim Biophys Acta; 2002 Aug; 1564(1):57-65. PubMed ID: 12100996
[TBL] [Abstract][Full Text] [Related]
12. Influence of gp41 fusion peptide on the kinetics of poly(ethylene glycol)-mediated model membrane fusion.
Haque ME; Lentz BR
Biochemistry; 2002 Sep; 41(35):10866-76. PubMed ID: 12196026
[TBL] [Abstract][Full Text] [Related]
13. Solid-state nuclear magnetic resonance measurements of HIV fusion peptide 13CO to lipid 31P proximities support similar partially inserted membrane locations of the α helical and β sheet peptide structures.
Gabrys CM; Qiang W; Sun Y; Xie L; Schmick SD; Weliky DP
J Phys Chem A; 2013 Oct; 117(39):9848-59. PubMed ID: 23418890
[TBL] [Abstract][Full Text] [Related]
14. Effect of cholesterol on the interaction of the HIV GP41 fusion peptide with model membranes. Importance of the membrane dipole potential.
Buzón V; Cladera J
Biochemistry; 2006 Dec; 45(51):15768-75. PubMed ID: 17176099
[TBL] [Abstract][Full Text] [Related]
15. Fusion-competent state induced by a C-terminal HIV-1 fusion peptide in cholesterol-rich membranes.
Apellániz B; Nieva JL
Biochim Biophys Acta; 2015 Apr; 1848(4):1014-22. PubMed ID: 25617671
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides.
Egelhofer M; Brandenburg G; Martinius H; Schult-Dietrich P; Melikyan G; Kunert R; Baum C; Choi I; Alexandrov A; von Laer D
J Virol; 2004 Jan; 78(2):568-75. PubMed ID: 14694088
[TBL] [Abstract][Full Text] [Related]
17. Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study.
Kliger Y; Aharoni A; Rapaport D; Jones P; Blumenthal R; Shai Y
J Biol Chem; 1997 May; 272(21):13496-505. PubMed ID: 9153194
[TBL] [Abstract][Full Text] [Related]
18. Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion.
Wang S; York J; Shu W; Stoller MO; Nunberg JH; Lu M
Biochemistry; 2002 Jun; 41(23):7283-92. PubMed ID: 12044159
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of membrane-associated fusion peptide secondary structure and lipid mixing function of HIV gp41 constructs that model the early pre-hairpin intermediate and final hairpin conformations.
Sackett K; Nethercott MJ; Epand RF; Epand RM; Kindra DR; Shai Y; Weliky DP
J Mol Biol; 2010 Mar; 397(1):301-15. PubMed ID: 20080102
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanism.
Judice JK; Tom JY; Huang W; Wrin T; Vennari J; Petropoulos CJ; McDowell RS
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13426-30. PubMed ID: 9391041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
